Mucolytic and anti-inflammatory effects of inhaled heparin in cystic fibrosis and chronic obstructive pulmonary disease

Mucolytic and anti-inflammatory effects of inhaled heparin in cystic fibrosis and chronic obstructive pulmonary disease

Bibliographic Details
Main Author:	Serisier, David John
Published:	University of Southampton 2004
Subjects:	616.24061
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.430498

Similar Items

Pulmonary infection in cystic fibrosis : microbiology and antibiotic treatment at the site of infection
by: Moriarty, T. F. M.
Published: (2006)

Physiological and inflammatory markers of response to pharmacological intervention in chronic obstructive pulmonary disease
by: Borrill, Zoe
Published: (2008)

Pharmacological modulation of an 'in vivo' model of airway inflammation
by: McCluskie, Kerryn
Published: (2004)

Carbocysteine sulphoxidation and its effect on mucoactivity
by: Boonyapiwat, Boontarika
Published: (2005)

The role of prostanoids and isoprostanes in airway inflammation
by: Clarke, Deborah Lee
Published: (2003)

Sensing mechanisms of prostacyclin and related molecules in cardiovascular tissues
by: Ali, Ferhana Yasmeen
Published: (2006)

Novel anti-inflammatory and mucolytic effects of heparin in vitro
by: Broughton-Head, Victoria Jane
Published: (2005)

Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum
by: Shute Janis K, et al.
Published: (2009-07-01)

Developing non-human primate models of chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF)
by: Bowden, Alexandra
Published: (2010)

Inflammatory profiles in chronic obstructive pulmonary disease and asthma
by: Saha, Shironjit K.
Published: (2010)

A MUCOLYTIC WITH ANTIINFLAMMATORY QUALITIES FOR CHILDREN SUFFERED FROM CYSTIC FIBROSIS: DORNASE ALFA
by: O. I. Simonova, et al.
Published: (2012-12-01)

Pulmonary colonisation of patients with cystic fibrosis by Pseudomonas aeruginosa
by: Nelson, J. W.
Published: (1991)

Pulmonary colonisation of patients with cystic fibrosis by Burkholderia cepacia
by: Butler, Sarah Louise
Published: (1994)

Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis
by: Kalina R. Atanasova, et al.
Published: (2018-08-01)

Cystic fibrosis related osteoporosis : does the systemic inflammatory response to pulmonary infection influence osteoclast formation and activity?
by: Shead, Elizabeth F.
Published: (2006)

Anaerobic pulmonary infection in cystic fibrosis : detection, characterisation and treatment
by: Field, Tyler Robert
Published: (2008)

Effects of acute and chronic antigen inhalation on airway inflamation and function and anti-inflammatory drug interventions
by: Evans, Rhys
Published: (2009)

Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial.
by: Martin Koppitz, et al.
Published: (2016-01-01)

Host proteolytic and inflammatory responses due to anaerobic infection in cystic fibrosis
by: Jackson, Megan
Published: (2015)

Cognitive function in cystic fibrosis and cystic fibrosis related diabetes (CFRD)
by: Chadwick, Helen Kay
Published: (2016)

The macrophage in cystic fibrosis
by: Wright, Adam
Published: (2007)

Inflammatory potential of Prevotella species isolated from the airways of cystic fibrosis patients
by: Matier, Thomas Bailie
Published: (2016)

Discovering inflammatory biomarkers in chronic obstructive pulmonary disease and cystic fibrosis : a case study of granzyme B
by: Ngan, David Allen
Published: (2011)

Discovering inflammatory biomarkers in chronic obstructive pulmonary disease and cystic fibrosis : a case study of granzyme B
by: Ngan, David Allen
Published: (2011)

Discovering inflammatory biomarkers in chronic obstructive pulmonary disease and cystic fibrosis : a case study of granzyme B
by: Ngan, David Allen
Published: (2011)

The role of heparin in inflammatory bowel disease
by: Shetty, Ajeya Krishna
Published: (2011)

The development of radio-nuclide imaging techniques to assess airways inflammation and inhaled drug delivery in patients with asthma and chronic obstructive pulmonary disease
by: Marino, Philip Serafin
Published: (2009)

Assessing the long-term clinical effectiveness of inhaled and anti-inflammatory therapies for lung disease in cystic fibrosis
by: Singh, Sachinkumar B. P.
Published: (2014)

Glucose tolerance in cystic fibrosis
by: Dobson, Lee
Published: (2004)

Blood monocytes in cystic fibrosis
by: Rao, Satish Ramakrishna
Published: (2009)

Airways inflammation in cystic fibrosis
by: Downey, D. G.
Published: (2002)

Lung infection in cystic fibrosis
by: Hurley, Matthew
Published: (2016)

Airway clearance in cystic fibrosis
by: McIlwaine, Patricia Margaret
Published: (2014)

The use of impedance pH measurements to determine the effect of gastro-oesophageal reflux in patients with idiopathic pulmonary fibrosis and cystic fibrosis
by: Krishnan, Amaran
Published: (2014)

Early pulmonary rehabilitation for exacerbations of chronic obstructive pulmonary disease
by: Greening, Neil James
Published: (2014)

Association of breath glucose with pulmonary disease in cystic fibrosis : assessment of a potential new biomarker
by: Srivastava, Shelley
Published: (2012)

Investigation of the role of glucose in airway secretions in the pathogenesis of pulmonary decline in cystic fibrosis related diabetes
by: Brennan, Amanda L.
Published: (2011)

Development of rapid tools for the early diagnosis of Pseudomonas aeruginosa pulmonary infection in patients with cystic fibrosis
by: Weisner, Abbie Michelle
Published: (2008)

Pharmacotherapy of cystic fibrosis: inhaled antibiotics
by: N. I. Kapranov
Published: (2013-12-01)

LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSIS
by: N.I. Romanenko, et al.
Published: (2006-03-01)